Description

Buy Odin Ibutamoren 30mg 30tabs (MK677)

Product Overview

Odin Ibutamoren 30mg 30 Tablets delivers a potent, orally active growth hormone secretagogue in a convenient tablet format. Each tablet contains 30mg of Ibutamoren (MK-677), a non-peptide compound that mimics the action of ghrelin to stimulate endogenous growth hormone (GH) and insulin-like growth factor-1 (IGF-1) release. This product is designed for research purposes and is supplied in a 30-tablet count, providing a full course of study material.

Mechanism of Action

Ibutamoren functions as a potent agonist of the growth hormone secretagogue receptor (GHSR), also known as the ghrelin receptor. By binding to and activating this receptor, Ibutamoren triggers a signaling cascade within the hypothalamus and pituitary gland that leads to increased release of growth hormone-releasing hormone (GHRH) and amplification of the pituitary’s response to GHRH.

A key characteristic of Ibutamoren’s action is its ability to enhance the natural, pulsatile pattern of GH secretion rather than inducing a constant, non-physiological release. This preservation of the endocrine feedback loop represents a significant advantage over exogenous GH administration.

Clinical studies have demonstrated that Ibutamoren significantly increases both the amplitude of GH pulses and the overall 24-hour GH concentration. In healthy elderly subjects receiving 25mg daily, GH levels increased by 97 percent. In obese men, an 1.8-fold increase in GH was observed at one year.

Clinical Research and Effects

Multiple clinical trials have investigated the effects of Ibutamoren on the GH/IGF-1 axis in various populations, including healthy adults, obese individuals, and GH-deficient patients. Key findings from clinical research include:

• Increased GH and IGF-1 Levels: In a two-year clinical trial involving healthy adults aged 60 to 81 years, participants receiving 25mg of MK-677 daily experienced a 1.8-fold increase in 24-hour mean GH and a 1.5-fold increase in IGF-1 levels from baseline.

• Changes in Body Composition: The same trial demonstrated that mean fat-free mass decreased by 0.5 kg in the placebo group while increasing by 1.1 kg in the MK-677 group. Body weight increased by 0.8 kg in the placebo group and 2.7 kg in the MK-677 group.

• Anabolic Effects: MK-677 has been shown to reverse diet-induced nitrogen wasting, suggesting potential utility in treating catabolic conditions.

• Increased Energy Expenditure: In obese subjects, treatment with MK-677 increased growth hormone secretion, fat-free mass, and energy expenditure.

Dosage and Administration

Clinical trials have utilized oral doses of Ibutamoren ranging from 2mg to 50mg per day. A common dose used in many studies is 25mg once daily. Ibutamoren is typically administered once a day, often at bedtime to mimic the natural nocturnal peak in GH secretion.

For research purposes, a common dosing strategy is 10-25mg daily, typically taken at night to align with natural GH cycles. Many experienced researchers begin at 10mg to 15mg daily for the initial phase of study.

Product Specifications

---

Top 10 Frequently Asked Questions

1. What is Ibutamoren (MK-677)?

Ibutamoren, also known as MK-677, is an orally active, non-peptide growth hormone secretagogue that mimics the action of ghrelin, stimulating the release of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). It functions as an agonist of the growth hormone secretagogue receptor (GHSR).

2. What is the recommended dosage for research purposes?

Clinical trials have used oral doses ranging from 2mg to 50mg per day. A common research dose is 25mg once daily. Many researchers begin at 10mg to 15mg daily for the initial phase and adjust based on tolerance and observations.

3. How should Ibutamoren be administered?

Ibutamoren is administered orally, typically once a day. Many protocols recommend taking it at bedtime to mimic the natural nocturnal peak in GH secretion.

4. Is Ibutamoren approved by the FDA?

No. There are no FDA-approved drug products containing ibutamoren mesylate as the active ingredient. Ibutamoren is not approved for human consumption and is considered an investigational compound.

5. What are the reported side effects?

Commonly reported side effects include increased appetite, water retention, insulin resistance, weight gain, fatigue, muscle pain, joint pain, headaches, and mood changes. Long-term use may increase the risk of developing type 2 diabetes. Clinical trials have also reported mild, transient muscle pain that typically subsides within a few months.

6. Does Ibutamoren affect blood glucose and insulin sensitivity?

Yes. Clinical studies have shown that Ibutamoren can increase fasting glucose levels and decrease insulin sensitivity. In a two-year trial, participants experienced an average increase of 0.3 mmol/L (5 mg/dL) in fasting glucose. MK-677 has also been reported to increase fasting blood glucose levels and heighten the risk of hyperglycemia.

7. Is Ibutamoren legal to use?

Ibutamoren is not approved for human use and is not legal for use as an ingredient in dietary supplements or consumer products. It is listed on the World Anti-Doping Agency Prohibited List and is prohibited at all times in sport. The FDA has issued warning letters to companies illegally selling products containing MK-677.

8. What is the half-life of Ibutamoren?

The half-life of Ibutamoren is approximately 24 hours, allowing for once-daily dosing.

9. Can Ibutamoren be detected in drug tests?

Yes. Ibutamoren (MK-0677) can be detected in hair, urine, and plasma following oral administration. It is included on the WADA Prohibited List and is subject to testing in athletic competition.

10. Are there any drug interactions to be aware of?

Ibutamoren may interact with medications and products, including selective androgen receptor modulators (SARMs). When combined with SARMs, MK-677 could negatively impact serum lipids, liver enzymes, and testosterone levels.

---

Important Safety Information

Ibutamoren (MK-677) is an investigational compound that has not been approved by the FDA for human consumption. It is prohibited by the World Anti-Doping Agency and is not legal for use as a dietary supplement ingredient.

Reported adverse effects include insulin resistance, increased appetite, weight gain, water retention, fatigue, muscle pain, alterations in glucose metabolism, and potential increases in the risk of congestive heart failure. Long-term safety has not been established, and the full extent of potential side effects remains unknown.

This product is intended for research purposes only and should not be used for human consumption. Always consult with a qualified healthcare professional before beginning any research protocol involving investigational compounds.

---

References and Reputable Sources

• FDA – Ibutamoren Information

• PubMed – Growth Hormone Secretagogue MK-677 Clinical Trial

• Get Smart About Drugs – MK-677 Health Risks

• OPSS – Performance Enhancing Substance: MK-677

• Sport Integrity Australia – Ibutamoren Information

• World Anti-Doping Agency Prohibited List

---

Odin Ibutamoren 30mg 30 Tablets (MK-677) is available now for research purposes. Visit https://anabolicsteroidsonline.shop/ to place your order today. Secure your supply of this high-quality research compound and advance your investigative studies with confidence.